Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Sanofi

Abbott Signs Partnership With Omada To Expand FreeStyle Libre Users

Abbott signed a deal with Omada Health to integrate Abbott's FreeStyle Libre with Omada's health coaching platform.

Commercial Deals

Pfizer's Abrocitinib Looks Competitive In Atopic Dermatitis

The first detailed Phase III results for the company's next-generation oral JAK inhibitor abrocitinib appear to show efficacy on par or better than data from Sanofi/Regeneron's Dupixent and may give Lilly's Olumiant a run for its money in AD.

Clinical Trials Research and Development Strategies

French OTC Industry Warns Over-Regulation Is Threatening Its Future

Plans to move ibuprofen, aspirin and paracetamol OTCs behind the counter in French pharmacies will harm the country's self-medication industry, which is already lagging behind its European neighbors, warns local association Afipa.
France OTC Drugs

'Buy China' In Procurement Schemes - Should You Worry?

A recent trade group report points to a rising and alarming "Buy China" trend in procurement rounds in the country. Although largely in medical device bidding, it may potentially affect the pharma sector, an analysis from the recent “4+7” centralized bidding scheme show.

China Commercial
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register